Regenerex Pharma (RGPX) Income from Continuing Operations (2010 - 2025)
Regenerex Pharma (RGPX) reported Income from Continuing Operations of 790659.0 for Q3 2025, down 50.73% year-over-year from 1604861.26 in Q3 2024, and down 20.3% on a QoQ basis from 657266.0 in Q2 2025.
Regenerex Pharma (RGPX) has 13 years of Income from Continuing Operations data on file, last reported at 790659.0 in Q3 2025.
- Quarterly Income from Continuing Operations fell 50.73% year-over-year to 790659.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 3092068.0 (down 117.86% YoY) and the FY2025 annual result came in at 2143427.0, up 39.56% from the prior year.
- Income from Continuing Operations eased to 790659.0 in Q3 2025 per RGPX's latest filing, from 657266.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 24430.0 in Q2 2021 and bottomed at 2805724.0 in Q3 2023.
- The 5-year median for Income from Continuing Operations is 219141.5 (2023), against an average of 438473.94.
- The widest annual swing landed in 2023, when Income from Continuing Operations sank 7261.98%; it then soared 81.3% in 2024.
- Tracing RGPX's Income from Continuing Operations over 5 years: stood at 76523.0 in 2021, then surged by 39.44% to 46343.0 in 2022, then slumped by 460.18% to 259603.0 in 2023, then slumped by 30.4% to 338526.0 in 2024, then plunged by 133.56% to 790659.0 in 2025.
- Per Business Quant, the three latest RGPX Income from Continuing Operations figures stand at 790659.0 (Q3 2025), 657266.0 (Q2 2025), and 1305617.0 (Q1 2025).
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -790,659.00 |
| Jun 30, 2025 | -657,266.00 |
| Mar 31, 2025 | -1.31 Mn |
| Dec 31, 2024 | -338,526.00 |
| Sep 30, 2024 | -524,541.00 |
| Jun 30, 2024 | -276,613.00 |
| Mar 31, 2024 | -358,539.00 |
| Dec 31, 2023 | -259,603.00 |
| Sep 30, 2023 | -2.81 Mn |
| Jun 30, 2023 | -178,680.00 |
| Mar 31, 2023 | -94,177.00 |
| Dec 31, 2022 | -46,343.00 |
| Sep 30, 2022 | -38,111.00 |
| Jun 30, 2022 | -32,803.00 |
| Mar 31, 2022 | -46,463.00 |
| Dec 31, 2021 | -76,523.00 |
| Sep 30, 2021 | -37,913.00 |
| Jun 30, 2021 | -24,430.00 |
| Dec 31, 2020 | -25,455.00 |
| Sep 30, 2020 | -22,765.00 |
| Jun 30, 2020 | -19,426.00 |
| Mar 31, 2020 | -21,632.00 |
| Dec 31, 2019 | -20,656.00 |
| Sep 30, 2019 | -18,384.00 |
| Jun 30, 2019 | -31,122.00 |
| Mar 31, 2019 | -46,077.00 |
| Dec 31, 2018 | -52,290.00 |
| Sep 30, 2018 | -4,820.00 |
| Jun 30, 2018 | -18,569.00 |
| Mar 31, 2018 | -13,950.00 |
| Dec 31, 2017 | -10,254.00 |
| Sep 30, 2017 | -8,144.00 |
| Jun 30, 2017 | -17,103.00 |
| Mar 31, 2017 | -8,144.00 |
| Aug 31, 2014 | -59,573.00 |
| May 31, 2014 | -169,935.00 |
| Aug 31, 2013 | -245,932.00 |
| May 31, 2013 | -247,677.00 |
| Aug 31, 2011 | -16,048.00 |
| Aug 31, 2010 | -17,843.00 |